ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ: ZYBT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.92
+5.75% today
Updated 2026-04-30
Market cap
$43.72M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $14
Volume
0.3M
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $31.81M | $17.34M | $48.18M | $41.05M | $41.05M |
| Capital expenditures | $26.40M | $27.33M | $11.60M | $27.77M | $27.77M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — |
| Free cash flow | $5.41M | $-9.99M | $36.58M | $13.27M | $13.27M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | $11.05M | $21.43M | $39.45M | $16.02M | $16.02M |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |